Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in Patients With Type II Diabetes Mellitus

NCT05164263 is registered in ClinicalTrials.gov with Getz Pharma as lead sponsor.

NCT NCT05164263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05164263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in Patients With Type II Diabetes Mellitus
Lead sponsor
Getz Pharma
Phase
Phase 4
Overall status
Recruiting
Start date
April 1, 2021
Completion date
August 31, 2027
Enrollment
2,000 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

efficacy, self, safety issues, type ii diabetes mellitus